Journal of Neuroscience study examines medicinal properties of cannabis
OHSU research suggests an avenue for developing treatments for chronic pain that harness the medicinal properties of cannabis while minimizing the threat of addiction.
The study, conducted in a rodent model, provides additional rationale for the development of therapeutics using cannabinoid receptors to treat chronic pain, which afflicts about 30 percent of the U.S. population. OHSU investigators studied the function of two forms of cell membrane receptors that bind cannabinoids that occur naturally within the body, called endocannabinoids.
“It may be an avenue where we can get better pain medications that are not addictive,” said senior author Susan Ingram, Ph.D., an associate professor of neurosurgery in the OHSU School of Medicine.
Ingram and colleagues report the treatment of chronic pain has challenged the medical system, with medications that are ineffective or create serious side effects: “However, emerging data indicate that drugs that target the endocannabinoid system might produce analgesia with fewer side effects compared with opioids.”
The body’s endocannabinoid system comprises receptors, endocannabinoid molecules and enzymes that make and degrade the endocannabinoids located in the brain and throughout the central and peripheral nervous system. The research team focused on two cannabinoid receptors, known as CB1 and CB2, in the rostral ventromedial medulla – a group of neurons located in the brainstem known to modulate pain. The study is the first to examine CB1 and CB2 receptor function at the membrane level in late adolescent and adult neurons.
The researchers observed that chronic inflammatory pain increased activity of CB2 receptors and decreased CB1 activity. Cannabis activates both CB1 and CB2 receptors equally. The study suggests that selective activation of CB2 receptors contributes to the medicinal benefit of cannabis while minimizing the propensity of the other cannabinoid receptor, CB1, to induce tolerance and withdrawal. Ingram said the next phase of the research will further explore this area of brain circuitry, which ultimately could lead to the development of a new class of pain medications.
Receive an email update when we add a new PAIN article.
The Latest on: Non-addictive pain relief
via Google News
The Latest on: Non-addictive pain relief
- FDA picks Isaiah House for clinical trialon October 15, 2021 at 7:00 pm
Isaiah House, a Christian-based rehabilitation center based in Kentucky, will be part of a U.S. Food and Drug Administration clinical trial into a non-pharmacological medical device for Opioid ...
- Has COVID-19 Helped or Hindered the Opioid Crisis?on October 15, 2021 at 11:00 am
Two chronic pain experts explain how the coronavirus epidemic affected the opioid epidemic, plus what we can do about it now.
- NET gain: Isaiah House will be part of clinical trial for device that could curb addictionon October 14, 2021 at 1:33 pm
Isaiah House, a Christian-based rehabilitation center based in Kentucky, will be part of a U.S. Food & Drug Administration clinical trial into a non-pharmacological medical device ...
- Innovation-Based Discernment To Drive The Non Opioid Pain Treatment Marketon October 13, 2021 at 8:20 pm
The global Non Opioid Pain Treatment Market is bound to witness a CAGR worth satiating In Upcoming Years In the era of cloud computing the cloud revolution is there to break the stereotypes Several ...
- Worth Watching: ‘Dopesick’ on Hulu, Harry Ambrose Back in ‘Sinner,’ a ‘Wonder’-filled ABC Lineup, Disney+ Goes ‘Beyond’on October 13, 2021 at 4:00 am
Hulu’s powerful limited-series docudrama "Dopesick" is a devastating look at how OxyContin was falsely marketed as a non-addictive pain treatment, fueling the opioid crisis.
- Levitee Labs Signs Letter of Intent to Acquire Calgary Addiction and Compounding Pharmacyon October 12, 2021 at 6:12 am
Signed LOI to acquire a compounding pharmacy in Calgary, Alberta, Canada ; Valuation of approximately 3.5x TTM EBITDA of $180,000; Levitee Labs to use compounding capabilities to ...
- Healing From Within? Psychedelic Assisted Therapyon October 11, 2021 at 8:45 pm
I was working in a community health clinic in Madison, WI when one of the addiction medicine physicians I had worked alongside of asked me a most unexpected question in between patients: “Are you in ...
- Does acupuncture have a place in the operating room?on October 11, 2021 at 9:42 am
One new study suggests that giving patients acupuncture during total joint replacement procedures reduces their pain, leading to the need for fewer opioids for postoperative pain. The researchers ...
- 1 in 5 People Still Use Opioids 3 Months After Surgeryon October 10, 2021 at 9:23 pm
Experts say healthcare professionals need to be aware of a person's risk of opioid addiction before surgery is performed.
via Bing News